Blog | Worldwide Clinical Trials https://www.worldwide.com/insights/ Thu, 18 Apr 2024 17:55:14 +0000 en-US hourly 1 https://wordpress.org/?v=6.5.2 https://www.worldwide.com/wp-content/uploads/2023/04/cropped-favicon-32x32.png Blog | Worldwide Clinical Trials https://www.worldwide.com/insights/ 32 32 Schizophrenia Clinical Development at Worldwide Clinical Trials https://www.worldwide.com/insights/explore-worldwides-experience-in-schizophrenia-clinical-trials/ Thu, 18 Apr 2024 04:00:00 +0000 https://www.worldwide.com/insights/schizophrenia-clinical-development-at-worldwide-clinical-trials/ At Worldwide, we leverage our deep scientific knowledge and robust clinical research capabilities to advance the programs of sponsors revolutionizing the treatment of schizophrenia. With more than 100 years of combined expertise across our strategic and operational leads, we are leading the charge in advancing psychiatric care, providing innovative and impactful solutions tailored to the complexities of mental health disorders. Read our fact sheet to learn more

The post Schizophrenia Clinical Development at Worldwide Clinical Trials appeared first on Worldwide Clinical Trials.

]]> At Worldwide, we leverage our deep scientific knowledge and robust clinical research capabilities to advance the programs of sponsors revolutionizing the treatment of schizophrenia. With more than 100 years of combined expertise across our strategic and operational leads, we are leading the charge in advancing psychiatric care, providing innovative and impactful solutions tailored to the complexities of mental health disorders. Read our fact sheet to learn more

The post Schizophrenia Clinical Development at Worldwide Clinical Trials appeared first on Worldwide Clinical Trials.

]]> Revolutionizing Drug Development Through Bioanalytical Excellence: Enabling Automation in Bioanalysis for Optimal Results https://www.worldwide.com/insights/worldwide-clinical-trials-innovative-total-lab-automation-system/ Thu, 04 Apr 2024 04:00:00 +0000 https://www.worldwide.com/insights/revolutionizing-drug-development-through-bioanalytical-excellence-enabling-automation-in-bioanalysis-for-optimal-results/ Discover the future of bioanalysis with Worldwide Clinical Trials’ innovative Total Lab Automation (TLA) system. Our cutting-edge solution addresses the industry’s most pressing challenges, enhancing assay lifecycle management, reducing study timelines, minimizing deviations, and cutting costs through advanced automation.

The post Revolutionizing Drug Development Through Bioanalytical Excellence: Enabling Automation in Bioanalysis for Optimal Results appeared first on Worldwide Clinical Trials.

]]> Discover the future of bioanalysis with Worldwide Clinical Trials’ innovative Total Lab Automation (TLA) system. Our cutting-edge solution addresses the industry’s most pressing challenges, enhancing assay lifecycle management, reducing study timelines, minimizing deviations, and cutting costs through advanced automation.

The post Revolutionizing Drug Development Through Bioanalytical Excellence: Enabling Automation in Bioanalysis for Optimal Results appeared first on Worldwide Clinical Trials.

]]> In-House Clinical Assessment Technologies at Worldwide https://www.worldwide.com/insights/in-house-clinical-assessment-technologies-fact-sheet/ Tue, 26 Mar 2024 04:00:00 +0000 https://www.worldwide.com/insights/in-house-clinical-assessment-technologies-at-worldwide/ Our in-house Clinical Assessment Technologies (CAT) team ensures the highest quality data and consistency across your studies, specializing in seamless assessment training, scale and translation management, and endpoint quality management. We’re committed to reducing errors, improving accuracy, and ensuring the reliability of outcome data. See how this in-house team supports our sponsors!

The post In-House Clinical Assessment Technologies at Worldwide appeared first on Worldwide Clinical Trials.

]]> Our in-house Clinical Assessment Technologies (CAT) team ensures the highest quality data and consistency across your studies, specializing in seamless assessment training, scale and translation management, and endpoint quality management. We’re committed to reducing errors, improving accuracy, and ensuring the reliability of outcome data. See how this in-house team supports our sponsors!

The post In-House Clinical Assessment Technologies at Worldwide appeared first on Worldwide Clinical Trials.

]]> The Emergence of PROs in Oncology https://www.worldwide.com/insights/pros-in-oncology-white-paper/ Mon, 11 Mar 2024 04:00:00 +0000 https://www.worldwide.com/insights/the-emergence-of-pros-in-oncology/ Now that oncology patients are surviving longer, survival rate alone is insufficient for novel therapy evaluations. Patient-reported outcomes (PROs) offer an improved option for research outcomes. Check out this comprehensive and actionable guide for integrating PROs into your oncology trial.

The post The Emergence of PROs in Oncology appeared first on Worldwide Clinical Trials.

]]> Now that oncology patients are surviving longer, survival rate alone is insufficient for novel therapy evaluations. Patient-reported outcomes (PROs) offer an improved option for research outcomes. Check out this comprehensive and actionable guide for integrating PROs into your oncology trial.

The post The Emergence of PROs in Oncology appeared first on Worldwide Clinical Trials.

]]> Q&A: Harmonizing Bioanalytical Method Validation – Navigating the Complex Landscape of Global Regulatory Standards https://www.worldwide.com/insights/guide-to-bioanalytical-method-validation/ Thu, 29 Feb 2024 05:00:00 +0000 https://www.worldwide.com/insights/qa-harmonizing-bioanalytical-method-validation-navigating-the-complex-landscape-of-global-regulatory-standards/ Developing and introducing a new bioanalytical technique to the market is a time-consuming and expensive process, often taking years to meet regulatory benchmarks. The challenge intensifies when seeking approval in multiple markets simultaneously. The International Council for Harmonization (ICH) worked to address this issue, providing guidance starting January 21, 2023, to harmonize regulatory standards. While not universally adopted, many regulatory bodies consider ICH guidelines, facilitating greater harmonization and streamlining international approval processes. Adhering to these standards can significantly reduce time and costs in the clinical development pipeline. However, despite efforts, variations in interpretation still exist among bioanalytical testing facilities. Our recent white paper addresses common questions and suggests approaches to harmonize these differences. Download today for more information.

The post Q&A: Harmonizing Bioanalytical Method Validation – Navigating the Complex Landscape of Global Regulatory Standards appeared first on Worldwide Clinical Trials.

]]> Developing and introducing a new bioanalytical technique to the market is a time-consuming and expensive process, often taking years to meet regulatory benchmarks. The challenge intensifies when seeking approval in multiple markets simultaneously. The International Council for Harmonization (ICH) worked to address this issue, providing guidance starting January 21, 2023, to harmonize regulatory standards. While not universally adopted, many regulatory bodies consider ICH guidelines, facilitating greater harmonization and streamlining international approval processes. Adhering to these standards can significantly reduce time and costs in the clinical development pipeline. However, despite efforts, variations in interpretation still exist among bioanalytical testing facilities. Our recent white paper addresses common questions and suggests approaches to harmonize these differences. Download today for more information.

The post Q&A: Harmonizing Bioanalytical Method Validation – Navigating the Complex Landscape of Global Regulatory Standards appeared first on Worldwide Clinical Trials.

]]> The Power of Pharmacogenomics: Revolutionizing the Approach to Clinical Trials Through Genetic Insights https://www.worldwide.com/insights/a-cro-for-pharmacogenomics-revolutionizing-clinical-trials/ Wed, 28 Feb 2024 05:00:00 +0000 https://www.worldwide.com/insights/the-power-of-pharmacogenomics-revolutionizing-the-approach-to-clinical-trials-through-genetic-insights/ Our white paper provides an overview of pharmacogenomics (PGx) and its vital role in understanding how genetic variations affect an individual’s response to drugs. Highlights include the importance of PGx in supporting personalized medicine initiatives post approval, and focusing on the pivotal role it plays in enhancing drug safety and efficacy within clinical trials. Download our white paper today to learn more:

The post The Power of Pharmacogenomics: Revolutionizing the Approach to Clinical Trials Through Genetic Insights appeared first on Worldwide Clinical Trials.

]]> Our white paper provides an overview of pharmacogenomics (PGx) and its vital role in understanding how genetic variations affect an individual’s response to drugs. Highlights include the importance of PGx in supporting personalized medicine initiatives post approval, and focusing on the pivotal role it plays in enhancing drug safety and efficacy within clinical trials. Download our white paper today to learn more:

The post The Power of Pharmacogenomics: Revolutionizing the Approach to Clinical Trials Through Genetic Insights appeared first on Worldwide Clinical Trials.

]]> Shifting Perceptions of CRO Service Providers: Large vs. Midsize CROs https://www.worldwide.com/insights/industry-report-on-cro-service-providers-large-midsize-cros/ Mon, 29 Jan 2024 05:00:00 +0000 https://www.worldwide.com/insights/shifting-perceptions-of-cro-service-providers-large-vs-mid-size-cros/ We recently conducted a web-based, quantitative survey among 140 CRO key decision-makers at biotech and pharmaceutical companies of all sizes, unraveling the nuances between large and midsize CROs. Discover overall satisfaction trends, the impact of these nuances on sponsor partnerships, and much more in our industry report:

The post Shifting Perceptions of CRO Service Providers: Large vs. Midsize CROs appeared first on Worldwide Clinical Trials.

]]> We recently conducted a web-based, quantitative survey among 140 CRO key decision-makers at biotech and pharmaceutical companies of all sizes, unraveling the nuances between large and midsize CROs. Discover overall satisfaction trends, the impact of these nuances on sponsor partnerships, and much more in our industry report:

The post Shifting Perceptions of CRO Service Providers: Large vs. Midsize CROs appeared first on Worldwide Clinical Trials.

]]> Rescuing Two Disease Monitoring Programs https://www.worldwide.com/insights/rescuing-two-programs-case-study/ Fri, 19 Jan 2024 05:00:00 +0000 https://www.worldwide.com/insights/rescuing-two-disease-monitoring-programs/ Deciding to bring in a new CRO to rescue a struggling study is a difficult decision to make. Then, after selecting the CRO, the transition process can be time-consuming and challenging. Check out this case study to see why this sponsor decided a rescue was warranted and how our approach successfully transitioned the studies, leaving the sponsor confident in the long-term success of both studies.

The post Rescuing Two Disease Monitoring Programs appeared first on Worldwide Clinical Trials.

]]> Deciding to bring in a new CRO to rescue a struggling study is a difficult decision to make. Then, after selecting the CRO, the transition process can be time-consuming and challenging. Check out this case study to see why this sponsor decided a rescue was warranted and how our approach successfully transitioned the studies, leaving the sponsor confident in the long-term success of both studies.

The post Rescuing Two Disease Monitoring Programs appeared first on Worldwide Clinical Trials.

]]> Successful Special Procedure Study Conduct: CSF and Concurrent Muscle Biopsy https://www.worldwide.com/insights/a-cro-for-successful-special-procedure-study-conduct/ Mon, 15 Jan 2024 05:00:00 +0000 https://www.worldwide.com/insights/successful-special-procedure-study-conduct-csf-and-concurrent-muscle-biopsy/ Special procedure study conduct can be challenging and not every CRO can accommodate based on your studies requirements. See how we supported cerebrospinal fluid (CSF) and concurrent muscle biopsy procedures in this case study.

The post Successful Special Procedure Study Conduct: CSF and Concurrent Muscle Biopsy appeared first on Worldwide Clinical Trials.

]]> Special procedure study conduct can be challenging and not every CRO can accommodate based on your studies requirements. See how we supported cerebrospinal fluid (CSF) and concurrent muscle biopsy procedures in this case study.

The post Successful Special Procedure Study Conduct: CSF and Concurrent Muscle Biopsy appeared first on Worldwide Clinical Trials.

]]> Worldwide Clinical Trials’ Early Phase and Bioanalytical Service Offerings https://www.worldwide.com/insights/video-explore-our-bioanalytical-lab-clinical-pharmacology-unit/ Fri, 12 Jan 2024 05:00:00 +0000 https://www.worldwide.com/insights/worldwide-clinical-trials-early-phase-and-bioanalytical-service-offerings/ Our bioanalytical lab and clinical pharmacology unit are within one-hour driving distance from each other, offering a comprehensive approach that enhances our clients’ success through streamlined vendor management, consistent standards, and overall efficiencies in project management. Learn more about our capabilities in this video.

The post Worldwide Clinical Trials’ Early Phase and Bioanalytical Service Offerings appeared first on Worldwide Clinical Trials.

]]> Our bioanalytical lab and clinical pharmacology unit are within one-hour driving distance from each other, offering a comprehensive approach that enhances our clients’ success through streamlined vendor management, consistent standards, and overall efficiencies in project management. Learn more about our capabilities in this video.

The post Worldwide Clinical Trials’ Early Phase and Bioanalytical Service Offerings appeared first on Worldwide Clinical Trials.

]]>